Robin Mansukhani

CEO and Co-Founder of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age related diseases. Locally, he has been an advisor to early stage biotechs, particularly in the Aging and CNS space, including Therini Bio and Reservoir Neurosciences.

Related Organizations

Articles from this author

September 17, 2025

Lifespan Research Institute Launches Public Longevity Group

[Mountain View, September 17, 2025] — Lifespan Research Institute (LRI) today announced the launch of the Public Longevity Group (PLG), a new initiative focused on bridging the cultural gap between scientific breakthroughs in aging and their public acceptance. To kickstart its work, PLG has opened a crowdfunding campaign to develop tools that measure and strengthen...